Monashee Investment Management LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1627608
Institutional-grade research for retail investors

13F Reported Value

$183.8M

Holdings

45

Latest Filing

2026-03-31

Filing Quarter

Q1 2026

Portfolio Overview

Monashee Investment Management LLC disclosed 45 positions worth $183.8M in its Form 13F-HR for Q1 2026, led by $TERN (Terns Pharmaceuticals, Inc.) at 8.6% of the equity portfolio. During the quarter the fund opened 30 new positions and exited 24 and a full exit from $SOFI. The portfolio is most concentrated in Healthcare (49.1% of disclosed assets). All figures are sourced directly from Monashee Investment Management LLC’s Form 13F-HR filing with the SEC under CIK 1627608.

Sector Allocation

HealthcareOtherTechnologyUtilitiesFinancialsIndustrials

AUM History

Top Equity Holdings by Value

Quarterly Activity — Q1 2026

Click any card to unlock

Top Holdings

AI Quality Scored

Unlock AI quality scores for every holding

32-signal composite ranking on each of Monashee Investment Management LLC's 45 positions.

Showing top 10 of 45 holdings.

Sector Allocation

Healthcare

$90.3M

Other

$35.4M

Technology

$22.4M

Utilities

$13.9M

Financials

$8.8M

Industrials

$6.0M

Communication Services

$3.7M

Energy

$2.1M

Full Holdings — Monashee Investment Management LLC (Q1 2026)

All 45 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

#TickerCompanyValueWeightQoQQuality
1TERN$TERNTerns Pharmaceuticals, Inc.$15.8M8.6%+52%
2NEXTERA ENERGY INC$15.2M8.3%NEW
3MDLN$MDLNMedline Inc.$13.3M7.3%+0%
4NRG$NRGNRG ENERGY, INC.$12.4M6.8%NEW59.5
5FPS$FPSForgent Power Solutions, Inc.$10.2M5.6%NEW
6SLDB$SLDBSolid Biosciences Inc.$10.2M5.6%+5%
7NKTR$NKTRNEKTAR THERAPEUTICS$7.2M3.9%+6%10.2
8CYTK$CYTKCYTOKINETICS INC$6.6M3.6%+33%28
9JOBY AVIATION INC$5.9M3.2%NEW
10PPL CORP$5.2M2.9%NEW
11BBIO$BBIOBridgeBio Pharma, Inc.$5.0M2.7%-33%31.7
12ADT$ADTADT Inc.$4.6M2.5%+75%66.2
13ORACLE CORP$4.5M2.5%NEW
14EVMN$EVMNEvommune, Inc.$4.1M2.2%-2%
15KKR$KKRKKR & Co. Inc.$4.0M2.2%NEW49.8
16ASTS$ASTSAST SpaceMobile, Inc.$3.7M2.0%NEW29.6
17ZENAS BIOPHARMA INC$3.2M1.8%NEW
18SNDK$SNDKSandisk Corp$3.2M1.7%NEW88.8
19MANE$MANEVeradermics, Inc$3.2M1.7%NEW
20ZBIO$ZBIOZenas BioPharma, Inc.$2.9M1.6%NEW14.4
21KYMR$KYMRKymera Therapeutics, Inc.$2.9M1.6%-65%29.2
22AMBQ$AMBQAmbiq Micro, Inc.$2.6M1.4%+22%46.3
23MMED$MMEDMiniMed Group, Inc.$2.6M1.4%NEW
24FIGR$FIGRFigure Technology Solutions, Inc.$2.6M1.4%NEW
25SGP$SGPSpyGlass Pharma, Inc.$2.5M1.3%NEW
26GPCR$GPCRStructure Therapeutics Inc.$2.4M1.3%-78%
27CRSP$CRSPCRISPR Therapeutics AG$2.4M1.3%NEW4.5
28INGM$INGMIngram Micro Holding Corp$2.3M1.3%NEW60.3
29GFS$GFSGLOBALFOUNDRIES Inc.$2.2M1.2%NEW
30ENGN$ENGNenGene Therapeutics Inc.$2.2M1.2%+8%
31FLOC$FLOCFlowco Holdings Inc.$2.1M1.1%NEW66.3
32SABS$SABSSAB Biotherapeutics, Inc.$1.9M1.0%NEW
33ACRS$ACRSAclaris Therapeutics, Inc.$1.9M1.0%NEW9.2
34HNRG$HNRGHALLADOR ENERGY CO$1.5M0.8%NEW50.4
35NVGS$NVGSNavigator Holdings Ltd.$1.4M0.8%NEW
36HELIX ACQUISITION CORP III$1.4M0.8%NEW
37CMPX$CMPXCompass Therapeutics, Inc.$1.4M0.7%-74%
38BTGO$BTGOBITGO HOLDINGS, INC.$1.2M0.7%NEW
39COHR$COHRCOHERENT CORP.$1.2M0.7%NEW64
40JAN$JANJanus Living, Inc.$1.2M0.6%NEW
41WYFI$WYFIWhiteFiber, Inc.$952,8000.5%-43%43.5
42VIR$VIRVir Biotechnology, Inc.$896,0000.5%NEW5.6
43GOSS$GOSSGossamer Bio, Inc.$845,2820.5%+16%27.1
44NRGV$NRGVEnergy Vault Holdings, Inc.$582,2950.3%NEW12
45MSLE$MSLESatellos Bioscience Inc.$67,5600.0%NEW

New Positions (30)

NEXTERA ENERGY INC$15.2M
NRG$NRG NRG ENERGY, INC.$12.4M
FPS$FPS Forgent Power Solutions, Inc.$10.2M
JOBY AVIATION INC$5.9M
PPL CORP$5.2M
ORACLE CORP$4.5M
KKR$KKR KKR & Co. Inc.$4.0M
ASTS$ASTS AST SpaceMobile, Inc.$3.7M
ZENAS BIOPHARMA INC$3.2M
SNDK$SNDK Sandisk Corp$3.2M
MANE$MANE Veradermics, Inc$3.2M
ZBIO$ZBIO Zenas BioPharma, Inc.$2.9M
MMED$MMED MiniMed Group, Inc.$2.6M
FIGR$FIGR Figure Technology Solutions, Inc.$2.6M
SGP$SGP SpyGlass Pharma, Inc.$2.5M

Exited Positions (24)

SOFI$SOFI SoFi Technologies, Inc.
ULS$ULS UL Solutions Inc.
INSM$INSM INSMED Inc
MIAX$MIAX MIAMI INTERNATIONAL HOLDINGS, INC.
LGN$LGN Legence Corp.
IMNM$IMNM Immunome Inc.
ITT$ITT ITT INC.
WLTH$WLTH WEALTHFRONT CORP
SO$SO SOUTHERN CO
NOVT$NOVT NOVANTA INC
LMRI$LMRI Lumexa Imaging Holdings, Inc.
DYN$DYN Dyne Therapeutics, Inc.
AERO$AERO Grupo Aeromexico, S.A.B. de C.V.
EQV VENTURES AC CORP. II
KYTX$KYTX Kyverna Therapeutics, Inc.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for Monashee Investment Management LLC including:

Full 13F portfolio with all holdings
Quarter-over-quarter position changes
Accumulation & distribution patterns
Sector allocation breakdown
Historical portfolio evolution
New positions & complete exits
Concentration analysis
Peer comparison with similar funds
AI-powered portfolio insights

Track Monashee Investment Management LLC's Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Monashee Investment Management LLC and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: Monashee Investment Management LLC

13F Pro is an AI hedge fund tracker and stock research platform. For Monashee Investment Management LLC (SEC CIK: 1627608), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Monashee Investment Management LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.